Evidence map›Paper›PMID 30364761›Full record

ArticleHeliyon2018

Effectiveness of a single intra-articular bone marrow aspirate concentrate (BMAC) injection in patients with grade 3 and 4 knee osteoarthritis.

George S Themistocleous, George D Chloros, Ioannis M Kyrantzoulis, Ioannis A Georgokostas, Marios S Themistocleous, Panayiotis J Papagelopoulos, Olga D Savvidou

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Heliyon, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03898388 (A Prospective Analysis Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx® SD Treatment), which is not on this map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03898388 naterminatednot on this mapstarted 2019, after this paper: background citation

A Prospective Analysis Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx® SD Treatment: A Multi-Site Study

TypeinterventionalSponsorRegenexx, LLCRan2019 to 2022Enrolled47ConditionsKnee OsteoarthritisArmsBone Marrow Concentrate treatment
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Adipose-derived and bone marrow aspirate concentrate injections for osteoarthritis: A scoping review.PM & R : the journal of injury, function, and rehabilitation · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

George S ThemistocleousOrthoHeal Clinic for Regenerative Musculoskeletal Medicine, Athens, Greece.
George D ChlorosOrthoHeal Clinic for Regenerative Musculoskeletal Medicine, Athens, Greece.
Ioannis M KyrantzoulisOrthoHeal Clinic for Regenerative Musculoskeletal Medicine, Athens, Greece.
Ioannis A GeorgokostasOrthoHeal Clinic for Regenerative Musculoskeletal Medicine, Athens, Greece.
Marios S ThemistocleousOrthoHeal Clinic for Regenerative Musculoskeletal Medicine, Athens, Greece.
Panayiotis J PapagelopoulosFirst Department of Orthopaedic Surgery, National and Kapodistrian University of Athens, School of Medicine, "ATTIKON" University General Hospital, Athens, Hellenic Republic, Greece.
Olga D SavvidouFirst Department of Orthopaedic Surgery, National and Kapodistrian University of Athens, School of Medicine, "ATTIKON" University General Hospital, Athens, Hellenic Republic, Greece.
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the clinical efficacy and safety of an intra-articular injection of bone marrow aspirate concentrate (BMAC) as a treatment option for osteoarthritis (OA) of the knee. MATERIALS AND

methodsBetween June 2014 and February 2017, data from 233 patients with knee osteoarthritis treated with BMAC injection at a single center, were retrospectively evaluated. Only patients with idiopathic osteoarthritis were included. Exclusion criteria were post-traumatic osteoarthritis, previous knee surgery, age less than 50 years old or more than 85 years old, active infection, uncontrolled diabetes mellitus, rheumatological or other systemic disease, malignancy, or treatment with immunosuppressive drugs. Bone marrow from the iliac crest was aspirated/concentrated with a standardized technique using a single-spin manual method. Patients were evaluated before and after the procedure, using the numeric pain scale (NPS) and Oxford knee score (OKS). Mean follow-up period was 11 months, range (6-30 months).

resultsA total of 121 of 233 patients had completed data as previously defined and were included in the statistical analysis. There were 85 females and 36 males, with mean age 70 years (range 50-85). Compared to baseline, the mean NPS decreased from 8.33 to 4.49 (p < 0.001) and the mean OKS increased from 20.20 to 32.29 (P < 0.001) at final follow-up. There were no complications.

conclusionA single intra-articular injection of BMAC is a safe and reliable procedure that results in clinical improvement of knee OA.

Indexed as

Evidence-based medicineSurgery

Identifiers

PMID30364761
PMCPMC6197942
OpenAlexW2896627626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.